Group 1 - Shanghai Xinruize Chemical Co., Ltd. has been established with a registered capital of 200,000 RMB [1] - The legal representative of the company is Ren Qinghua [1] - The business scope includes sales of specialized chemical products (excluding hazardous chemicals), chemical products sales (excluding licensed chemical products), new material technology promotion services, import and export of goods, technology import and export, and warehousing equipment leasing services [1]

Core Viewpoint - Titan Technology (688133) has seen a stock price increase of 8.73% this week, closing at 27.4 yuan, with a total market capitalization of 4.506 billion yuan [1] Company Announcement Summary - Titan Technology plans to acquire 100% equity of Apollo Scientific Ltd. (ASL) for approximately 55.85 million yuan to expand its overseas sales channels [1] - The acquisition involves a payment of 5,756,429 GBP, which is about 55.85 million yuan, and is not classified as a related party transaction or a major asset restructuring [1] - ASL reported a revenue of 87.09 million yuan and a net loss of 5.5 million yuan for the year 2024 [1] - The transaction is subject to approval from relevant national and local authorities and will be included in the company's consolidated financial statements upon completion [1] - The acquisition is expected to enhance the company's core competitiveness and diversify its product line [1]

证券代码：688133 证券简称：泰坦科技 公告编号：2025-029 上海泰坦科技股份有限公司 关于拟收购境外公司股权并签署股权收购协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 对外投资概况：上海泰坦科技股份有限公司（以下简称"公司"）拟使 用 自 有 或自筹 资 金 5,756,429 英镑（以 2025 年 7 月 23 日汇率 折合人 民币约 易 所 上 市公司 ， 股票代 码 4044 ，以下 简称" Central Glass 日本 "）持有的 Apollo Scientific Ltd.（英格兰注册的私人股份有限公司，以下简称"标的公 司"或"ASL"） 100%的股权。（以下简称"本次交易"） ? 本次交易不构成关联交易。 ? 本次交易不构成重大资产重组。 ? 交易实施尚需履行的审批及其他相关程序： 本次交易涉及境外投资，相关股权和资产的交割须符合所在地区法律规定和 监管部门要求。 ? 其它需要提醒投资者重点关注的风险事项： 由于交易架构复杂，交易双方分别为中国和日本证券交 ...